Perth-based pharmaceutical products commercialisation specialist Helicon Group Ltd will open its initial public offer today, aiming to raise $4 million to fund market research and pursuit of new opportunities in the Chinese and North Asian markets.

Perth-based pharmaceutical products commercialisation specialist Helicon Group Ltd will open its initial public offer today, aiming to raise $4 million to fund market research and pursuit of new opportunities in the Chinese and North Asian markets.